imiquimod bioadhesive gel (Ojer Pharma)

N/A

Report date: 2025/03/20 15:30:33
NME

Base Information

Drug Nameimiquimod bioadhesive gel (Ojer Pharma)
Drug Alias NameKeramod
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsKeratosis, ActinicCarcinoma, Basal CellCondylomata Acuminata
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Ojer Pharma
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Ojer Pharma
Inactive CompaniesN/A
Active IndicationsKeratosis, ActinicCarcinoma, Basal CellCondylomata Acuminata
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A